Yahoo Finance Plus 
The bad news for retirees is that while they are getting the biggest benefits increase in four decades, the 5.9% raise they'll receive in 2022 is still is likely to fall short of maintaining the buying power they enjoyed before. Retirees' COLA was calculated based on inflation data from July, August, and September of 2021.
This super investor is going against the herd. Maybe you should, too.
Last week, the S&P 500 finished Friday’s session with a rally that gave the index a small gain of 0.15% for the day. It was a good thing, too, since the index flirted with a net-20% loss during the session. That’s bear market territory, the kind of market move that will further spook investors after a springtime of headwinds. Inflation is running at 40-year high levels, Q1 showed a net economic contraction, Russia’s war on Ukraine promises to further damage supplies and prices in the food, cooki
(Reuters) -Brazil's right-wing president Jair Bolsonaro fired the chief executive of oil producer Petrobras - the second in two months - after the company refused to sell fuels at a discount to consumers warning it would lead to diesel shortages. Bolsonaro also called for the election of a new board, according to a statement released close to midnight local time on Monday by the state-controlled company, opening the way to a full executive management shake-up. José Mauro Ferreira Coelho is the third Petrobras CEO fired by Bolsonaro over fuel prices.
(Bloomberg) -- Snap Inc. cut its revenue and profit forecasts below the low end of its previous guidance, sending shares plunging as much as 31% and pushing other social media stocks down.Most Read from BloombergBroadcom in Talks to Acquire Cloud Company VMwareStocks Climb in Risk-On Day While Bonds Decline: Markets WrapBiden Misspeaks on Taiwan, Says US Military Would InterveneRussian Diplomat Quits in Rare Public Protest Over War in UkraineBiden’s Latest Taiwan Gaffe Stokes Tensions With Beiji
It's all about time in the market. Not timing the market.
The giants of Wall Street are looking at the same markets tumult, and drawing very different conclusions on when the carnage might end.
Dow Jones futures were lower, while tech futures sold off late Monday. Stocks to buy and watch include Tesla supplier Livent.
(Bloomberg) -- Dennis Gartman is telling prospective dip buyers to sell any rallies in US stocks during a bear market that he dates to the start of the year, and expects to last for many months.Most Read from BloombergBroadcom in Talks to Acquire Cloud Company VMwareStocks Climb in Risk-On Day While Bonds Decline: Markets WrapBiden Misspeaks on Taiwan, Says US Military Would InterveneWalmart’s Troubles Should Have Everyone on High AlertGoldman’s Solomon Says Subway Shooting of Employee a ‘Sensel
The Russian ruble has emerged as the best-performing currency in 2022, despite wide-ranging sanctions imposed for its invasion of Ukraine. How did the Russian currency make a dramatic recovery from its record low of 143 rubles to the dollar on March 7? The rally, experts say, is largely artificial, the result of capital controls imposed by Moscow in the wake of Western sanctions.
Catalyst Biosciences Inc (NASDAQ: CBIO) has agreed to sell its portfolio of protease medicines that regulate complement to Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) for $60 million. "This sale is part of the ongoing strategic process that we announced in February to explore alternatives and create value for shareholders. We have significantly reduced our cash burn and continue to work with our advisors to evaluate additional strategic alternatives for Catalyst," said Nassim Usman, CEO o
Mizuho Managing Director Siti Panigrahi checks out Zoom's Q1 earnings, sustaining subscriber growth, and the communications technology company's business outlook.
On an otherwise good day for financial stocks and the markets generally, shares of Upstart (NASDAQ: UPST), a fintech lending platform based on artificial intelligence (AI), were falling today, and were down around 7.2% as of 3:40 p.m. ET. On Friday, Wedbush analyst David Chiaverini, who already had an underperform rating on Upstart, lowered his price target even further, from $20 to $15. Chiaverini cited a Kroll rating of a recent Upstart securitization, or rather a lack thereof, as indicating Upstart's class B and C notes were showing increased delinquencies and credit deterioration.
Over the last two years, Nvidia (NVDA) has made a habit of delivering “beat and raise” earnings reports. With the chip giant reporting F1Q21’s financials after the close on Wednesday, May 25, are investors in for another treat? Not according to Susquehanna’s Christopher Rolland. “Unlike recent quarters,” said the 5-star analyst, “we believe any significant beat and raise may be capped by Gaming headwinds.” So, what are these headwinds constraining Nvidia’s biggest breadwinner? Well for one, reta
The electric-car maker is breaking key support levels that fundamental investors might want to note.
To put it tactfully, cruise ship operator stocks haven't been very popular with investors over the past few years. The prognosticator lowered his price targets for both Carnival and Norwegian Monday morning before market open. In his opinion, Carnival is now worth $18 per share; previously, Didora's level was $22.
If a major recession is coming, the financial guru recommends some fast, concrete moves to protect your money.
Snap stock tumbles 30% after warning about deteriorating economy, sending other tech stocks falling. Is Snap the canary in the coal mine?
Yahoo Finance Live anchors discuss China stocks as Didi proceeds to delist from the New York Stock Exchange.
"Are you kidding me?!" Vergara's former co-star Sarah Hyland reacted to the racy shot.
Growing concern about the emergence of monkeypox in Europe and the U.S. has sent shares of several vaccine and drug companies soaring. At least three cases have been confirmed in the U.S. over the past year, including one in an adult male who recently traveled from Canada to Massachusetts. Several companies that have developed smallpox vaccines or therapeutics have seen their shares prices jump, and some of those drug makers may be familiar to investors who paid close attention to stocks that got a boost in early 2020 after China first disclosed the outbreak of the new coronavirus in Wuhan that was eventually identified as SARS-CoV-2.
Yahoo Finance